Research Article
The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients: A Retrospective Single-Center Study
Table 1
Anthropometric data, antidiabetic therapy, and laboratory parameters of diabetic, SIRS 24 h, and SOFA 24 h septic patients.
| | Diabetic, septic patients | | Criteria | SIRS 24 h group | SOFA 24 h group |
| | Number of patients (n) | 73 (47f/26m) | 34 (21f/13m) | | Age (years) | 72.8 ± 12.7 | 73.9 ± 12.3 | | Type 2 diabetes (n) | 73 | 34 | | Comorbidities | | Hypertension (n; %) | 67 (91.8) | 31 (91.2) | | Dyslipidemia (n; %) | 31 (42.5) | 12 (35.3) | | IHD/AMI/PCI/CABG (n; %) | 32 (43.8) | 18 (52.9) | | TIA/stroke (n; %) | 15 (20.6) | 6 (17.7) | | Peripheral arterial disease (n; %) | 42 (57.5) | 18 (52.9) | | Chronic kidney disease (n; %) | 27 (37.0) | 13 (38.2) | | Antidiabetic medications | | Metformin (n; %) | 30 (41.1) | 11 (32.4) | | Sulphonyl urea (n; %) | 24 (32.9) | 10 (29.4) | | DPP4 (n; %) | 4 (5.5) | 0 | | Insulin (n; %) | 18 (24.7) | 11 (32.4) | | Laboratory parameters | | Glucose (mmol/l) | 11.5 (7.7–16.3) | 12.05 (8.5–19.2) | | HbA1C (%) | 7.47 ± 1.8 | 7.26 ± 1.9 | | Urea (mmol/l) | 8.4 (6–12.3) | 9.85 (6.2–19.4) | | Creatinine (µmol/l) | 99 (77–137) | 118 (95–172) | | Glomerular filtration rate (ml/min1.73 m2) | 52 (38–75) | 42 (27–61) | | C-reactive protein (mg/l) | 77 (21–151.5) | 108 (21.3–246.3) | | AST (U/L) | 21 (17–33.5) | 25 (16–42) | | GGT (U/L) | 35 (21–69) | 40 (16–124) | | ALT (U/L) | 21 (14–32) | 21 (14–37) | | Total bilirubin (µmol/l) | 10 (6.5–17.4) | 11.2 (6.3–33.6) | | White blood cell count (G/L) | 15.8 ± 6.1 | 17.3 ± 7.3 | | Red blood cell count (T/L) | 4.3 ± 0.7 | 4.3 ± 0.7 | | Hemoglobin concentration (g/l) | 129.8 ± 22.3 | 133.8 ± 19.4 | | Thrombocyte (G/L) | 252.6 ± 76.9 | 251.0 ± 92.8 | | Length of hospital stay (day) | 8 (6–11.5) | 8 (7–11.5) |
|
|
Data are presented as mean ± standard deviation or median (lower-upper quartile).
|
